FINWIRES · TerminalLIVE
FINWIRES

Magnetic Resources Investors Approve Genesis Minerals Acquisition

By

Magnetic Resources (ASX:MAU) said its shareholders approved the proposed scheme of arrangement under which Genesis Minerals (ASX:GMD) will acquire 100% of the company, according to an Australian bourse filing on Wednesday after market hours.

Nearly 97% of shareholders present and voting at the scheme meeting and almost 100% of the total votes cast were in favor, per the filing.

The company will seek final approval from the Supreme Court of Western Australia on June 9. If granted, the scheme is expected to take effect on June 10, with Australian Securities Exchange trading suspended from that date, and the scheme implemented on June 22, the filing added.

Related Articles

Asia

Conrad Asia Energy CEO to Step Down

Conrad Asia Energy (ASX:CRD) said that Chief Executive Miltos Xynogalas will step down, effective Aug 31, according to an Australian bourse filing on Wednesday after market hours.Xynogalas will transition to an executive position focused on the company's Indonesian operations, business development, partner relations, and government engagement, per the filing.Peter Botten has been appointed executive chairman, overseeing capital markets, investor engagement, the Mako project through first gas, and Conrad's Aceh assets.The company will begin an immediate search for a new CEO, the filing added.

$ASX:CRD
Asia

Market Chatter: Bank Indonesia Vows Continued Support for Rupiah After Fresh Record Low

Indonesia's central bank said it will continue to take steps to support to rupiah as the local currency dropped to an all-time low on Wednesday, Reuters reported the same day, citing spokesperson Ramdan ​Prakoso.USD/IDR reached 18,037 earlier in the day but was trading at 17,966.5 as of 3:59 a.m. ET, according to Bloomberg data.The central bank will pull all levers at its disposal to maintain stability in the foreign exchange market amid ongoing global uncertainties, the report quoted Prakoso as saying.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$^JKSE
Asia

Hunan Warrant Pharmaceutical Subsidiary Gets China Approval for Eye Exam Dye

China's drug regulator granted Hunan Warrant Pharmaceutical (SHA:688799) subsidiary Hunan Warrant Pharmaceutical Chiral marketing approval for its fluorescein sodium chemical raw material.The chemical is used as dye for diagnostic fundus angiography and iris vascular fluorescein angiography for eye exams, according to a Wednesday filing with the Shanghai bourse.

$SHA:688799